Evidence map›Paper›PMID 38745522›Full record

Trial reportAmyotrophic lateral sclerosis & frontotemporal degeneration2024

An online intervention for carers to manage behavioral symptoms in motor neuron disease (MiNDToolkit): a randomized parallel multi-center feasibility trial.

E Mioshi, K Grant, E Flanagan, S Heal, H Copsey, R L Gould, M Hammond, L Shepstone, P A Ashford

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

E MioshiSchool of Health Sciences, University of East Anglia, Norwich, UK.ORCID 0000-0002-0066-868X
K GrantNorwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK.
E FlanaganNorwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK.
S HealMND Association Norfolk, Norwich & Waveney Branch, Norwich, UK.
H CopseyNorfolk MND Care and Research Network, Norwich and Norfolk University Hospitals, Norwich, UK, and.
R L GouldDivision of Psychiatry, University College London, London, UK.
M HammondNorwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK.
L ShepstoneNorwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK.
P A AshfordNorwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence on management of behavioral symptoms in motor neuron disease (MND) is lacking. The MiNDToolkit, an online psychoeducational platform, supports carers dealing with behavioral symptoms (BehSymp). The study objectives were to ascertain recruitment and retention rates, carer and healthcare professional (HCP) use of the platform, and completion of online assessments, to inform a full-scale trial.

settingEngland and Wales, across diverse MND services; recruitment from July/21 to November/22; last participant follow-up in March/23.

participantsCarers of people with motor neuron disease (PwMND) with BehSymp, recruited through MND services. After confirming eligibility, participants completed screening and baseline assessments online via the MiNDToolkit platform and were randomized centrally in a 1:1 ratio to MiNDToolkit or control.

interventionMiNDToolkit offered tailored modules to carers for the 3-month study period. Carers in the intervention group could receive additional support from MiNDToolkit trained HCPs. The control group was offered access to the intervention at the end of the study. Data were collected on platform usage and psychosocial variables. MAIN OUTCOMES: One hundred and fifty-one carers from 11 sites were invited to join the study (letter, face-to-face); 30 were screened; 29 were randomized. Fifteen people were allocated to the control arm; 14 to intervention. Carers were mostly female; median age for was 62.5 (IQR: 58, 68; intervention) and 57 (IQR: 56, 70; controls). Study retention was high (24/29 = 82.76%); carers engaged with the platform on average 14 times (median (IQR):14.0 (10.0, 18.5)) during the study period.

conclusionThe MiNDToolkit study was feasible and well accepted by carers and trained HCPs. A definitive trial is warranted.

Indexed as

CaregiversFeasibility StudiesMotor Neuron DiseaseAdultAgedBehavioral SymptomsFemaleHumansMaleMiddle AgedALSFTDAmyotrophic lateral sclerosisbehavioral symptomscaregivercarerfeasibilitymotor neurone diseasetrial

Identifiers

PMID38745522
PMCPMC11286211

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.